Assyro AI

FDA Orange Book · active-ingredient family

Dasiglucagon hydrochloride

Dasiglucagon hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:ZEGALOGUE · NDA 214231

1

Brand (NDA)

0

Generics (ANDA)

2

Listed patents

2

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
ZEGALOGUERLD×2ZEALAND PHARMANDA 214231Mar 22, 2021

Marketing exclusivity (2)

  • NCENew chemical entity exclusivity (5 years)

    Mar 22, 2026

    3 mo ago

  • NCENew chemical entity exclusivity (5 years)

    Mar 22, 2026

    3 mo ago

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11795204Jan 06, 2034in 7 yr 8 mo
U-3752
10442847Mar 22, 2035in 8 yr 11 mo
SubstanceProduct

Dasiglucagon hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.